Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jigucao Ganyan Granule is a Traditional Chinese Medicine (TCM) product developed by Conchen Pharmaceutical, a subsidiary of Consun Pharmaceutical Group. Formulated as granules for oral administration, it is primarily indicated for the treatment of acute infectious hepatitis, including both icteric (jaundice-associated) and non-icteric forms. The preparation is derived from *Abrus cantoniensis* (Jigucao), which is traditionally utilized in TCM for its heat-clearing, detoxifying, and liver-soothing properties. It is often used to resolve damp-heat in the liver and gallbladder, which is a common TCM diagnosis for hepatitis symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jigucao ganyan granule.